Quillmark Health and BB-Demo: negotiation next steps

Megan, Tasha, I'm copying Owen Tallis, our VP Sales, since he's now on the commercial side of this with me. Here's where we are. The Enterprise deal is in negotiation, at the deal value on the current paper. Our target on the calendar is Friday 31 July 2026 for signature, and I'd rather give you a realistic date than a hopeful one. To be transparent about sequencing: I understand commercial terms sit behind security clearance on your side, so I'm not asking Tasha to negotiate before Megan is satisfied. What I'd like is clarity on the path. Two questions: - Megan, are there findings still open from your review that we can still answer in writing? - Tasha, what does your process need from us to move the vendor file forward, and in what order? What would make this a yes? If the answer is that it won't be, I'd like to know that too. Thanks, Jordan

Jordan, Thank you for your note and for the information you have provided throughout the evaluation. Per our process, the evaluation has concluded. At this time, Quillmark Health has decided not to proceed with BB-Demo and will move forward with another vendor. Please treat the proposal as closed on our side. As a matter of policy, we do not provide detailed feedback on evaluation outcomes in writing. The vendor file is now closed and I will retain your documentation per our records requirements. We appreciate your time and effort, and that of your colleagues, over the course of the evaluation. Best regards, Tasha Greene, Procurement Director